I suspect the confusion we are having is CPRX received a breakthrough status under the orphan drug approval process and AMPE is hoping for a fast track decision after the phase 3 trial. See the other thread.
I am simply reporting what AMPE told me. Don't shoot the messenger. I have simply tried to report what I was told. Suggest someone else call them and ask. I received a return call within the day.